Multiple Assemblies exist for SMTL entry 3gd7
Crystal structure of human NBD2 complexed with N6-Phenylethyl-ATP (P-ATP); X-RAY DIFFRACTION 2.70 Å

	SMTL ID 3gd7.1 Ligands N-(2-phenylethyl)adenosine 5'-(tetrahydrogen triphosphate) Polypeptides Fusion complex of Cystic fibrosis transmembrane conductance regulator, residues 1193-1427 and Maltose/maltodextrin import ATP-binding protein malK, residues 219-371 Oligo-state monomer
	SMTL ID 3gd7.2 Ligands N-(2-phenylethyl)adenosine 5'-(tetrahydrogen triphosphate) Polypeptides Fusion complex of Cystic fibrosis transmembrane conductance regulator, residues 1193-1427 and Maltose/maltodextrin import ATP-binding protein malK, residues 219-371 Oligo-state monomer
	SMTL ID 3gd7.3 Ligands N-(2-phenylethyl)adenosine 5'-(tetrahydrogen triphosphate) Polypeptides Fusion complex of Cystic fibrosis transmembrane conductance regulator, residues 1193-1427 and Maltose/maltodextrin import ATP-binding protein malK, residues 219-371 Oligo-state monomer
	SMTL ID 3gd7.4 Ligands N-(2-phenylethyl)adenosine 5'-(tetrahydrogen triphosphate) Polypeptides Fusion complex of Cystic fibrosis transmembrane conductance regulator, residues 1193-1427 and Maltose/maltodextrin import ATP-binding protein malK, residues 219-371 Oligo-state monomer
	SMTL ID 3gd7.5 Ligands N-(2-phenylethyl)adenosine 5'-(tetrahydrogen triphosphate) Polypeptides Fusion complex of Cystic fibrosis transmembrane conductance regulator, residues 1193-1427 and Maltose/maltodextrin import ATP-binding protein malK, residues 219-371 Oligo-state homo-tetramer